Yali Friedman, Ph.D., is founder of
thinkBiotech and was publisher of the
Journal of Commercial Biotechnology for many years. His first book,
Building Biotechnology, has been used as a course text in dozens of biotechnology programs. His other books include
Best Practices in Biotechnology Education and
Best Practices in Biotechnology Business Development.
Scientific American also named Dr. Friedman as one of the 100 most influential people in biotechnology.
Dr. Friedman has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW global biotechnology scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in more than fifty countries, and has been invited to participate in biotechnology industry development forums for US federal agencies, international groups such as APEC and ASEAN, and for individual countries such as Canada, Germany, India, Japan, the Philippines, and Turkey.
Dr. Friedman taught biotechnology management at the National Institutes of Health for several years and continues to regularly guest-lecture for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times web property which was named to Forbes "Best of the Web" list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence platform based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.
